Section on Endocrinology, Metabolism, Nutrition and Renal Diseases, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, UPV/EHU, CIBERER, CIBERDEM, Barakaldo, Spain.
Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD, United States.
Front Endocrinol (Lausanne). 2020 Jul 3;11:433. doi: 10.3389/fendo.2020.00433. eCollection 2020.
The DICER1 syndrome is a multiple neoplasia disorder caused by germline mutations in the gene. In DICER1 patients, aggressive congenital pituitary tumors lead to neonatal Cushing's disease (CD). The role of in other corticotropinomas, however, remains unknown. To perform a comprehensive screening for variants in a large cohort of CD patients, and to analyze their possible contribution to the phenotype. We included 192 CD cases: ten young-onset (age <30 years at diagnosis) patients were studied using a next generation sequencing panel, and 182 patients (170 pediatric and 12 adults) were screened via whole-exome sequencing. In seven cases, tumor samples were analyzed by Sanger sequencing. Rare germline variants were found in seven pediatric patients with no other known disease-associated germline defects or somatic second hits. By immunohistochemistry, DICER1 showed nuclear localization in 5/6 patients. Variant transmission from one of the parents was confirmed in 5/7 cases. One patient had a multinodular goiter; another had a family history of melanoma; no other patients had a history of neoplasms. Our findings suggest that gene variants may contribute to the pathogenesis of non-syndromic corticotropinomas. Clarifying whether loss-of-function is disease-causative or a mere disease-modifier in this setting, requires further studies. ClinicalTrials.gov: NCT00001595.
DICER1 综合征是一种多发性肿瘤疾病,由 基因的种系突变引起。在 DICER1 患者中,侵袭性先天性垂体肿瘤导致新生儿库欣病(CD)。然而,在其他促肾上腺皮质激素瘤中, 的作用尚不清楚。 为了在大量 CD 患者中进行 基因变异的全面筛查,并分析其对表型的可能贡献。 我们纳入了 192 例 CD 病例:10 例发病年龄<30 岁的早发性病例采用下一代测序panel 进行研究,182 例患者(170 例儿科患者和 12 例成人患者)采用全外显子组测序进行筛查。在 7 例病例中,肿瘤样本通过 Sanger 测序进行分析。 在 7 例儿科患者中发现了罕见的种系 变异,这些患者没有其他已知的与疾病相关的种系缺陷或体细胞 二次打击。通过免疫组化,在 5/6 例患者中观察到 DICER1 的核定位。在 5/7 例病例中证实了从父母一方传递的变异。1 例患者有多发性结节性甲状腺肿;另 1 例患者有黑色素瘤家族史;无其他患者有肿瘤病史。 我们的发现表明, 基因变异可能导致非综合征性促肾上腺皮质激素瘤的发病机制。进一步的研究需要阐明在这种情况下, 功能丧失是否是疾病的致病因素还是仅仅是疾病的修饰因素。 临床试验.gov:NCT00001595。